HCA
HCA Healthcare, Inc. NYSE$433.09
After hrs
$427.18
-0.02%
Mkt Cap $99.9B
52w Low $330.00
45.5% of range
52w High $556.52
50d MA $500.76
200d MA $456.68
P/E (TTM)
15.1x
EV/EBITDA
10.1x
P/B
—
Debt/Equity
-8.3x
ROE
-107.8%
P/FCF
14.0x
RSI (14)
—
ATR (14)
—
Beta
1.37
50d MA
$500.76
200d MA
$456.68
Avg Volume
1.1M
About
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardio…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | TNS | 7.12 | 7.15 | +0.4% | 432.46 | +1.4% | +3.1% | -0.1% | +0.5% | +0.5% | +0.1% | — | — |
| Jan 27, 2026 | TNS | 7.46 | 8.01 | +7.4% | 505.84 | -1.2% | -2.9% | -4.6% | -3.5% | -1.8% | -1.3% | +4.0% | — |
| Oct 24, 2025 | TNS | 5.79 | 6.96 | +20.2% | 447.04 | +0.7% | +4.7% | +4.3% | +4.8% | +4.4% | +2.8% | +12.1% | — |
| Jul 25, 2025 | TNS | 6.29 | 6.84 | +8.7% | 334.32 | -0.7% | +1.9% | +3.0% | +6.2% | +5.9% | +6.8% | +20.5% | — |
| Apr 25, 2025 | TNS | 5.75 | 6.45 | +12.2% | 327.92 | -0.3% | +1.3% | +3.9% | +5.2% | +4.6% | +6.1% | +15.5% | — |
| Jan 24, 2025 | TNS | 6.13 | 6.22 | +1.5% | 313.07 | +1.0% | +6.0% | +5.0% | +4.6% | +6.9% | +5.4% | +2.1% | — |
| Oct 25, 2024 | TNS | 4.99 | 5.03 | +0.8% | 363.55 | -0.0% | -1.9% | -0.8% | -0.7% | -1.3% | -1.7% | -10.4% | — |
| Jul 23, 2024 | TNS | 4.85 | 5.53 | +14.0% | 340.17 | +1.2% | +1.1% | +3.7% | +4.3% | +5.5% | +6.2% | +12.6% | — |
| Apr 26, 2024 | TNS | 5.01 | 5.93 | +18.4% | 306.69 | +0.7% | +1.5% | +1.0% | +0.9% | +0.7% | +0.3% | +3.9% | — |
| Jan 30, 2024 | TNS | 5.06 | 5.93 | +17.2% | 301.59 | +0.6% | +1.1% | +4.3% | +2.6% | +3.0% | +1.7% | +3.4% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | TD Cowen | Maintains | Buy → Buy | — | $432.46 | $438.51 | +1.4% | +3.1% | -0.1% | +0.5% | +0.5% | +0.1% |
| Apr 27 | Oppenheimer | Maintains | Outperform → Outperform | — | $432.46 | $438.51 | +1.4% | +3.1% | -0.1% | +0.5% | +0.5% | +0.1% |
| Apr 27 | Barclays | Maintains | Overweight → Overweight | — | $432.46 | $438.51 | +1.4% | +3.1% | -0.1% | +0.5% | +0.5% | +0.1% |
| Apr 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $432.46 | $438.51 | +1.4% | +3.1% | -0.1% | +0.5% | +0.5% | +0.1% |
| Apr 27 | Stephens & Co. | Maintains | Overweight → Overweight | — | $432.46 | $438.51 | +1.4% | +3.1% | -0.1% | +0.5% | +0.5% | +0.1% |
| Apr 27 | Truist | Maintains | Buy → Buy | — | $432.46 | $438.51 | +1.4% | +3.1% | -0.1% | +0.5% | +0.5% | +0.1% |
| Apr 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $432.46 | $438.51 | +1.4% | +3.1% | -0.1% | +0.5% | +0.5% | +0.1% |
| Apr 27 | RBC Capital | Maintains | Outperform → Outperform | — | $432.46 | $438.51 | +1.4% | +3.1% | -0.1% | +0.5% | +0.5% | +0.1% |
| Mar 10 | TD Cowen | Maintains | Buy → Buy | — | $545.13 | $543.89 | -0.2% | -1.4% | -1.4% | -2.3% | -2.2% | -3.7% |
| Feb 25 | Mizuho | Maintains | Outperform → Outperform | — | $526.52 | $527.00 | +0.1% | +2.7% | -0.1% | +0.6% | +1.2% | +2.9% |
Recent Filings
8-K · 8.01
!! High
HCA Healthcare, Inc. -- 8-K 8.01: Material Event / Announcement
HCA Healthcare is redeeming $2.5 billion in senior notes due mid-2026, allowing the company to refinance or delever its balance sheet ahead of maturity.
Apr 27
8-K · 8.01
!! High
HCA Healthcare, Inc. -- 8-K 8.01: Material Event / Announcement
HCA Healthcare's Board declared a $0.78 quarterly dividend per share, payable June 30, 2026 to shareholders of record June 16, 2026, demonstrating continued capital returns to investors.
Apr 24
8-K
HCA Healthcare, Inc. -- 8-K Filing
HCA Healthcare announced executive compensation adjustments for its President and CFO alongside its Chief Operating Officer, reflecting organizational leadership structure changes.
Feb 25
8-K · 5.02
!!! Very High
Norwegian Cruise Line Holdings Ltd. -- 8-K 5.02: Executive Change
Norwegian Cruise Line Holdings appointed John W. Chidsey as President, a leadership change that may signal strategic direction shifts for the cruise operator's operational and growth initiatives.
Feb 12
8-K · 5.02
!!! Very High
NCL CORP Ltd. -- 8-K 5.02: Executive Change
Norwegian Cruise Line Holdings appointed John W. Chidsey as President, signaling potential strategic leadership changes that investors should monitor for operational and financial direction shifts.
Feb 12
Data updated apr 25, 2026 1:06pm
· Source: massive.com